Exploratory/Developmental Translational Grants for Borderline Personality

The summary for the Exploratory/Developmental Translational Grants for Borderline Personality grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Exploratory/Developmental Translational Grants for Borderline Personality: This is a reissue of RFA MH-03-001. The National Institute of Mental Health (NIMH) reaffirms its commitment to encouraging cutting-edge research and promoting the development of new investigators in the area of borderline personality disorder (BPD), which has not received research attention commensurate with its significance as a public health problem. In addition, based on the response to the previous Request for Applications (RFA), NIMH recognizes the potential of this extension of its translational research initiative to borderline personality for contributing to the desired research and correlated increase in research capacity. The purpose of this RFA is to invite new and amended exploratory/developmental (R21) applications that propose translations of basic science theories, methods and findings to clinical research concerning borderline personality disorder; examining BPD features and its relationship to putative causal factors and to other disorders, constructs, and variables. Applicants for exploratory/developmental R21 grants should be committed to pursuing the proposed line of research through subsequent research project grants (R01 or other appropriate grant mechanisms) using the outcome data obtained as a result of this RFA. Translations may involve basic theories, methods, and/or findings from modern psychometrics and measurement theory, basic behavioral science, social science, and neuroscience. The specific clinical research focus chosen by the applicant should reflect the potential for innovative, important, and scientifically sound translations to clinical research concerning borderline personality disorder.
Federal Grant Title: Exploratory/Developmental Translational Grants for Borderline Personality
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-MH-04-006
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: No deadline provided
Original Application Deadline: Dec 18, 2003
Posted Date: Sep 05, 2003
Creation Date: Jan 17, 2004
Archive Date: Jan 17, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH...
Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com